1. Home
  2. ALVR vs BEST Comparison

ALVR vs BEST Comparison

Compare ALVR & BEST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALVR
  • BEST
  • Stock Information
  • Founded
  • ALVR 2013
  • BEST 2007
  • Country
  • ALVR United States
  • BEST China
  • Employees
  • ALVR N/A
  • BEST N/A
  • Industry
  • ALVR Biotechnology: Biological Products (No Diagnostic Substances)
  • BEST
  • Sector
  • ALVR Health Care
  • BEST
  • Exchange
  • ALVR Nasdaq
  • BEST Nasdaq
  • Market Cap
  • ALVR 52.2M
  • BEST 53.1M
  • IPO Year
  • ALVR 2020
  • BEST N/A
  • Fundamental
  • Price
  • ALVR $0.40
  • BEST $2.62
  • Analyst Decision
  • ALVR Sell
  • BEST
  • Analyst Count
  • ALVR 5
  • BEST 0
  • Target Price
  • ALVR $1.00
  • BEST N/A
  • AVG Volume (30 Days)
  • ALVR 365.9K
  • BEST 22.1K
  • Earning Date
  • ALVR 11-12-2024
  • BEST 12-31-2024
  • Dividend Yield
  • ALVR N/A
  • BEST N/A
  • EPS Growth
  • ALVR N/A
  • BEST N/A
  • EPS
  • ALVR N/A
  • BEST N/A
  • Revenue
  • ALVR N/A
  • BEST $1,183,106,017.00
  • Revenue This Year
  • ALVR N/A
  • BEST N/A
  • Revenue Next Year
  • ALVR N/A
  • BEST N/A
  • P/E Ratio
  • ALVR N/A
  • BEST N/A
  • Revenue Growth
  • ALVR N/A
  • BEST 11.57
  • 52 Week Low
  • ALVR $0.40
  • BEST $1.85
  • 52 Week High
  • ALVR $1.05
  • BEST $2.77
  • Technical
  • Relative Strength Index (RSI)
  • ALVR 27.58
  • BEST 38.28
  • Support Level
  • ALVR $0.40
  • BEST $2.63
  • Resistance Level
  • ALVR $0.53
  • BEST $2.68
  • Average True Range (ATR)
  • ALVR 0.04
  • BEST 0.04
  • MACD
  • ALVR 0.00
  • BEST -0.00
  • Stochastic Oscillator
  • ALVR 1.35
  • BEST 25.00

About ALVR AlloVir Inc.

AlloVir Inc is a late clinical-stage cell therapy company. The company focuses on developing innovative allogeneic T-cell therapies to combat viral diseases. Their proprietary VST therapy platform enables the creation of off-the-shelf VSTs, addressing the urgent medical need for treating patients with limited viral disease treatment options. With a singular focus on research, development, and commercialization, the company's platform targets 11 devastating viruses, with posoleucel being the lead candidate addressing six viruses. Operating within one segment, the company is dedicated to preventing and treating severe viral-associated diseases through off-the-shelf VST therapies.

About BEST BEST Inc. each representing twenty (20)

BEST Inc is a supply chain company. It provides a New Retail platform that offers technology-enabled integrated solutions such as supply chain management, express delivery, freight, merchandise sourcing, cross-border supply chain, last-mile, financial and value-added services. The Group operates in the following operating segments, Supply chain management services, Freight, Global and Others. The Others category principally relates to cross-border logistic coordination services. The majority of revenue generated from Freight segment.

Share on Social Networks: